MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Depression as a risk factor for impulse compulsive disorders in Parkinson’s disease: a prospective survival study

J. Marín-Lahoz, F. Sampedro, S. Martinez-Horta, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

Meeting: 2019 International Congress

Abstract Number: 1590

Keywords: Behavioral abnormalities, Depression

Session Information

Date: Wednesday, September 25, 2019

Session Title: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Agora 3 West, Level 3

Objective: To longitudinally evaluate the role of depression in the development of impulse control disorders (ICD) in Parkinson’s disease (PD) patients.

Background: Depression has been associated with ICD in cross-sectional PD studies. However, prospective studies addressing the causality of this relationship are lacking.

Method: From Parkinson’s Progression Markers Initiative (PPMI) we included PD patients free of ICDs at baseline according to the Questionnaire for Impulsive-Compulsive Disorders in PD (QUIP). Patients were prospectively evaluated first quarterly and then biannually. Development of ICDs was defined as an increase of QUIP scores during follow up. Using survival proportional hazard models we studied the effect of baseline depression over ICD risk. We also evaluated this effect controlling for dopamine agonist use as a time dependent variable and for other potential confounders.

Results: Among 354 patients, 68 were depressed at baseline. The median follow up was 4.08 years. Depression at baseline was associated with higher ICD risk (hazard ratio, HR: 1.96, 95% CI 1.32-2.9, p<0.001). This risk remained significant after controlling for DA use (HR: 1.97, 95%CI 1.33-2.9, p<0.001), which was also independently linked to ICD development (HR: 1.87 95%CI 1.3-2.7, p<0.001). Hence, depressed patients faced an even higher ICD risk when receiving DA treatment. Controlling for multiple potential confounders also did not alter these results.

Conclusion: In PD, depression predisposes to the development of ICDs. This risk is magnified by DA use. Thus, DA should be used cautiously in depressed PD patients.

figure1

figure2

To cite this abstract in AMA style:

J. Marín-Lahoz, F. Sampedro, S. Martinez-Horta, J. Pagonabarraga, J. Kulisevsky. Depression as a risk factor for impulse compulsive disorders in Parkinson’s disease: a prospective survival study [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/depression-as-a-risk-factor-for-impulse-compulsive-disorders-in-parkinsons-disease-a-prospective-survival-study/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/depression-as-a-risk-factor-for-impulse-compulsive-disorders-in-parkinsons-disease-a-prospective-survival-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley